Drugs and Devices

The AANS/CNS Drugs and Devices Committee is actively engaged with the Food and Drug Administration (FDA) and other scientific, governmental, clinical and industry representatives to provide neurosurgical expertise on drugs, devices and biologics used to treat patients and to foster innovation and patient safety. These activities include recommending neurosurgeon experts to serve on the FDA Advisory panels, providing input on FDA Guidance Documents and testimony at panel meetings, as appropriate. In addition, organized neurosurgery is an official partner with the FDA's Network of Experts program to provide rapid clinical assistance to FDA reviewers. The AANS and CNS continue to advocate policies that will decrease the regulatory burden for medical-device innovation and ensure patient access to new and improved medical technology.

Advanced Search
Article Type
Topics
Date Published


Article

AANS/CNS Urge Neurosurgeons to Promote Safe Storage and Disposal of Opioids

Published: April 17, 2017
Promote safe storage and disposalof opioids and all medications. The American Medical Association Task Forceto Reduce Opioid Abuse strongly supportsthe education and awareness of physicians,patients, policymakers, and other keystakeholders regarding […]
  • Drugs and Devices
Article

Alliance Position Statement on Physician-Directed Applications

Published: March 17, 2017
Physician-Directed Applications Physician-directed applications, also known as “off-label”1 uses, are an integral component ofthe art and science of medical practice, particularly for specialty physicians. Using medicalexpertise and judgment, physicians may […]
  • Drugs and Devices
Article

Neurosurgeon Adnan Siddiqui, MD Presentation to FDA on Embolic Protection Device

Published: February 24, 2017
Perspective of a Neurosurgeon who treats Stroke Adnan H. Siddiqui, MD, PhDProfessor & Vice-Chairman Department of NeurosurgeryDirector Neurosurgical Stroke Service, Kaleida HealthChief Medical Officer, Jacobs Institute Presenting endorsed statement fromAmerican […]
  • Drugs and Devices
Letters

PCRC Letter to Senate Leadership Supporting 21st Century Cures

Published: December 1, 2016
RE: 21st Century Cures Act Dear Majority Leader McConnell and Minority Leader Reid: The undersigned members of the Physician Clinical Registry Coalition strongly support theprovisions of the 21st Century Cures […]
  • Drugs and Devices
  • Medical Liability Reform
  • Quality Improvement and Patient Safety
Letters

AANS and CNS Send Letter Urging House to Pass 21st Century Cures

Published: November 29, 2016
SUBJECT: 21st Century Cures Legislation Dear Speaker Ryan and Leader Pelosi: On behalf of the American Association of Neurological Surgeons (AANS) and Congress of NeurologicalSurgeons (CNS), we are writing to […]
  • Drugs and Devices
Article

Neurosurgery Comments at FDA Meeting on Off-label Use Communication

Published: November 9, 2016
Statementof theAmerican Association of Neurological SurgeonsCongress of Neurological Surgeonsbefore theFood and Drugs AdministrationPublic Hearingon the Subject ofManufacturer Communications ofPhysician-Directed Uses of Approved Medical ProductsNovember 9, 2016 My name is William […]
  • Drugs and Devices
Article

AANS and CNS Sign on to Reducing Opioid Abuse Advertisement

Published: May 18, 2016
Help save lives:Increase access to naloxone For more than 40 years, naloxone has beensaving the lives of people who overdose onan opioid. With the United States in the midstof an […]
  • Drugs and Devices
Letters

Neurosurgery Endorses the “Removing Barriers to Clinical Research Act”

Published: December 11, 2015
The Honorable Todd YoungU.S. House of RepresentativesWashington, DC 20515 Subject: Removing Barriers to Clinical Research Act Dear Representative Young, On behalf of the American Association of Neurological Surgeons (AANS) and […]
  • Drugs and Devices
  • Medical Liability Reform
Letters

AANS and CNS Letter Supporting Medical Controlled Substances Transportation Act

Published: October 15, 2015
SUBJECT: Medical Controlled Substances Transportation Act of 2015 Dear Rep. Sessions, On behalf of the American Association of Neurological Surgeons (AANS) and Congress of NeurologicalSurgeons (CNS), we want to provide […]
  • Drugs and Devices
  • Quality Improvement and Patient Safety